company background image
0QLN logo

Tecan Group LSE:0QLN Stock Report

Last Price

CHF 206.00

Market Cap

CHF 2.6b

7D

-1.1%

1Y

-41.3%

Updated

13 Dec, 2024

Data

Company Financials +

0QLN Stock Overview

Provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. More details

0QLN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends4/6

Rewards

Risk Analysis

No risks detected for 0QLN from our risk checks.

Tecan Group AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tecan Group
Historical stock prices
Current Share PriceCHF 206.00
52 Week HighCHF 392.00
52 Week LowCHF 200.00
Beta0.70
1 Month Change-3.65%
3 Month Change-26.59%
1 Year Change-41.29%
3 Year Change-61.27%
5 Year Change-25.42%
Change since IPO100.98%

Recent News & Updates

Recent updates

Shareholder Returns

0QLNGB Life SciencesGB Market
7D-1.1%5.7%-0.2%
1Y-41.3%-18.8%6.9%

Return vs Industry: 0QLN underperformed the UK Life Sciences industry which returned -18.7% over the past year.

Return vs Market: 0QLN underperformed the UK Market which returned 6.2% over the past year.

Price Volatility

Is 0QLN's price volatile compared to industry and market?
0QLN volatility
0QLN Average Weekly Movement5.2%
Life Sciences Industry Average Movement7.3%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.5%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0QLN has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0QLN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19803,000Achim von Leoprechtingwww.tecan.com

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution.

Tecan Group AG Fundamentals Summary

How do Tecan Group's earnings and revenue compare to its market cap?
0QLN fundamental statistics
Market capCHF 2.64b
Earnings (TTM)CHF 101.34m
Revenue (TTM)CHF 1.00b

26.1x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0QLN income statement (TTM)
RevenueCHF 1.00b
Cost of RevenueCHF 653.34m
Gross ProfitCHF 346.71m
Other ExpensesCHF 245.37m
EarningsCHF 101.34m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 12, 2025

Earnings per share (EPS)7.90
Gross Margin34.67%
Net Profit Margin10.13%
Debt/Equity Ratio17.8%

How did 0QLN perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

38%

Payout Ratio